Results 221 to 230 of about 3,447,982 (286)

MiR‐513a promotes human erythroid differentiation by modulating c‐Jun

FEBS Open Bio, EarlyView.
During early human erythropoiesis, miR‐513a promoted erythroid differentiation in primary human CD34+ hematopoietic stem‐progenitor cells and human TF‐1 erythroleukemic cells by indirectly decreasing c‐Jun and phospho‐c‐Jun expression, which are associated with increased GATA1 expression.
MinJung Kim, Brittany Taylor, Shannon Bolten, Christian L. Eberly, Mahliya Abdurahman, T. Michael Creed, Acong Yang, Taylor L. Hatchet, Tristan Dyson, Shuo Gu, Curt I. Civin, Tami J. Kingsbury   +11 more
wiley   +1 more source

Artificial intelligence in drug discovery from advanced molecular representation to pipeline applications. [PDF]

Front Bioinform
Zhou X, Tao W.
europepmc   +1 more source

Decreased cold‐sensing function of the transient receptor potential channel TRPM8 from tailed amphibians

FEBS Open Bio, EarlyView.
Despite frogs avoiding low temperatures, examination of four salamander species revealed that none avoided cold and all possessed cold tolerance. Functional analysis of TRPM8, a cold sensor, showed that all salamander TRPM8s had lost their cold sensitivity.
Tadahiro Sawao, Daiki Kobayashi, Shogo Hori, Osamu Saitoh   +3 more
wiley   +1 more source

Practical Challenges for the Implementation of AI-Based Image Analysis in Ophthalmology Research: Insights and Recommendations from a Swiss Multicentric Study. [PDF]

Klin Monbl Augenheilkd
Spitznagel T, Garweg JG, Eandi C, Grimaldi G, Menghini M, Ambresin A, Zweifel S, Somfai GM.   +7 more
europepmc   +1 more source

WheatIS data discovery

, 2018
openaire   +1 more source

Digital twins to accelerate target identification and drug development for immune‐mediated disorders

FEBS Open Bio, EarlyView.
Digital twins integrate patient‐derived molecular and clinical data into personalised computational models that simulate disease mechanisms. They enable rapid identification and validation of therapeutic targets, prediction of drug responses, and prioritisation of candidate interventions.
Anna Niarakis, Philippe Moingeon
wiley   +1 more source

AI-Driven Drug Discovery: Focus on Targets for Solid Tumors. [PDF]

Pharmaceutics
Wu J, He J, Ni Q, Li Z, Lin X, Zhao Z, Qiu L, Wang H, Li S, Shi C, Zhang Y, Gao H, Lu J.   +12 more
europepmc   +1 more source

Discovery of serum APOD as an early sarcopenia biomarker in older adults with low muscle mass: a cross-sectional proteomic and transcriptomic investigation. [PDF]

PeerJ
Wu J, He Q, Huang L.
europepmc   +1 more source

From discovery to delivery: a systems-based pathway for translating science into global and humanitarian health impact. [PDF]

Confl Health
Ramalingam B.
europepmc   +1 more source

From data to discovery: The rise of information-theoretic predictive models in drug development. [PDF]

Sci Rep
Saied H, Alfahad O, Aljaffer AA, AlOmari AK, Saleh MA, Malaekah E.   +5 more
europepmc   +1 more source